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1. Introduction 
Different opinions exist regarding surgical techniques in the case of primary 
hyperparathyroidism (PHPT). Traditionally, all patients who underwent surgery were given 
a bilateral neck exploration. 
Since the main cause of PHPT is solitary adenoma, Tibblin et al. (1982) described the 
possibility of performing a unilateral neck exploration. Up till that time, the greatest 
limitation for this technique was the lack of precision in preoperative localization protocols. 
Nowadays, thanks to 99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy (Fig 1) and high 
resolution ultrasonography, unilateral neck exploration is successfully applied. 99m-Tc-MIBI 
imaging has been widely acknowledged as a basic test for preoperative localization and 
planning of the operation, being the test of choice in patients with persistent or recurrent 
PHPT, suspect of ectopic adenomas or in those who have been submitted to thyroidectomy 
or to other previous neck operations (Papathanassiou et al., 2008). 
 
Fig. 1. Double phase 99mTc-MIBI scintigraphy: Planar images and early SPECT in a patient 
with a right inferior single adenoma. 
Besides, in many occasions, intraoperative intact parathyroid hormone (ioPTHi) detection 
allows a unilateral neck approach, avoiding extensive surgery and increasing success rates. 
Moreover, due to the use of other intraoperative methods, such as the gamma probe, it is 
possible to perform even more limited surgery (minimally invasive parathyroidectomy -MIP). 
At some medical centres, the combination of these techniques has allowed to perform 
outpatient surgery, with a clear benefit from the cost-efficiency point of view, compared to 
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general anaesthesia and much more extensive cervical dissection. Nevertheless, it should be 
kept in mind that in the case of minimally invasive methods patients must be carefully 
selected to make sure there is no multiglandular disorder (e.g., MEN or secondary 
hyperparathyroidism). 
Another intraoperative technique which needs further investigation is the use of portable 
gamma-cameras. As yet few studies with a limited number of patients have been published 
concerning this new technique.  
Consequently, PHPT surgical treatment differs in accordance with the surgeon’s preference 
and the availability of preoperative techniques. 
2. Gamma probe 
The same year when Norman & Chheda (1997) proposed the use of 99mTc-MIBI mapping to 
guide minimally invasive parathyroidectomy, Bonjer et al. (1997) suggested using a probe 
during a bilateral cervical exploration for intraoperative detection of parathyroid adenomas 
not visualised preoperatively by scintigraphy. 
The technique of intra-operative gamma-detection is based on the differences between the 
kinetics of MIBI in hyperfunctioning parathyroid tissue and in its surrounding tissue, 
including thyroid and lymph nodes. MIBI localizes non-specifically in the mitochondria and 
cytoplasm in response to elevated membrane potentials across the membrane bilayers. It is 
concentrated in tissues that have increased cell activity or higher numbers of mitochondria. 
The method consist in the intraoperative detection of the tissue to be extirpated, which 
shows uptake as a result of the radiotracer administered to the patient prior to surgery. 
Localization is carried out with a manual gamma radiation detector which the surgeon 
introduces into the surgical field (Fig 2). By means of an acoustic signal and a digital counter 
measuring over-background radioactive emissions (in vivo counting), the damaged tissue is 
localized and subsequently extirpated. 
 
Fig. 2. The surgeon introducing the gamma probe through the incision in a MIP due to a 
single adenoma. 
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A further advantage reported is that use of the gamma probe reduces surgery time. In 
addition, ex vivo counting of the extirpated tissue and counting of the empty parathyroid 
bed, after the excision of the adenoma, serve to assess how successful surgery was. 
This technique has been reported a sensitivity between 84.6% and 93% in localizing 
adenomas, and 63% in the case of disorders compromising multiple glands. 
Although this is the traditional way to perform radioguided surgery in hyperparathyroidism, 
it has been recently reported a case in which authors used a preoperative injection of 
macroaggregate human albumin (MAA) labeled with 99mTc into the lesion and 
ultrasonographic guidance to localize an ectopic parathyroid gland (Aliyev et al., 2010). 
2.1 Technique: Doses and time of injection 
There is a certain controversy in radioguided surgery with regard to the optimal dose and 
the optimal time of injection prior to the operative procedure. Norman & Chheda (1997) 
performed the MIBI scintigraphy on the day of surgery, thus reducing economic cost and 
radiation doses to the patients. However, in some cases this protocol does not allow 
planning the type of surgery, while most authors believe that in cases of thyroid pathology a 
bilateral exploration should be carried out instead of a minimally invasive surgery (Casara 
et al., 2002). For this reason, in areas of endemic goitre, it is preferable to apply a different- 
day protocol. Using the latter, Rubello et al. (2006a) propose to carry out a double tracer 
scintigraphy on the first day and to inject 37 MBq on the day of surgery, 10 to 30 minutes 
before the minimally invasive parathyroidectomy. In this way, the radiation dose to the 
surgery team is minimized and false negatives due to parathyroid adenomas with rapid 
washout are avoided (Rubello et al., 2003). 
On the other hand, the time from injection to surgery varies between several minutes 
(Rubello et al., 2006b) and 3-3.5 h prior to surgery (Dackiw et al., 2000; Mc Greal et al., 2001; 
Murphy & Norman, 1999), with some authors choosing the proper time depending on when 
the best ratio is reached between MIBI uptake by the parathyroid tissue and the 
surrounding tissues (Ugur et al., 2004).  
Doses ranging from 37MBq (Rubello et al., 2006b) to 740-925MBq (Goldstein et al., 2003; Mc 
Greal et al., 2001; Murphy & Norman, 1999) have been reported. In particular, we initially 
injected 740MBq, 3 h before surgery, but modified our protocol to 370MBq, 10-60 minutes 
before surgery, in order to reduce radiation doses while keeping the same detection ability.  
2.2 Ex vivo and in vivo counting 
There are also different approaches regarding the selection of the reference area to measure 
background: the thyroid gland (Chen et al., 2003, 2005; Takeyama et al., 2004; Ugur et al., 2004, 
2006), the lung vertex contralateral to the pathological thyroid gland (Rubello et al., 2003), the 
right shoulder (Takeyama et al., 2004), the central area of the neck (Goldstein et al., 2003), the 
lateral region of the incision (Friedman et al., 2007) or the post-exeresis thyroid bed (Mc Greal 
et al., 2001; Murphy & Norman, 1999; Takeyama et al., 2004; Ugur et al., 2004, 2006).  
Takeyama et al. (2004) use the in vivo counting as well as the ex vivo counting. The in vivo 
counting is used for the localization and removal of the tumor (with the background being 
obtained as the maximum of two measurements: one on the right shoulder and one on the 
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thyroidal isthmus). The completeness of the excision is confirmed by means of the ex vivo 
counting, which uses the Murphy & Norman procedure (1999) to calculate the 
corresponding percentage with respect to background. 
Ugur et al. (2006) compare the in vivo counting of the parathyroid lesion to the thyroidal 
background of the contralateral side and the ex vivo parathyroid counting to the post-
exeresis background of the surrounding normal tissues. 
Most authors (Chen et al., 2003, 2005; Dackiw et al., 2000; Goldstein et al., 2003; Mc Greal et 
al., 2001; Murphy & Norman, 1999; Olson et al. 2006; Takeyama et al., 2004), however, use 
the ex vivo counting alone. They confirm a correct exeresis by determining the ex vivo 
counting of the specimens and applying the so-called “rule of 20” (i.e., ex vivo counts must 
exceed background by at least 20%). They generally consider the post-exeresis bed as 
background. When the suspected adenoma is removed, there is a radioactivity decline there 
and all quadrants show an equal score count (Norman & Chheda, 1997).  
According to Rubello et al. (2003a, 2003b), a value for the index determined by the bed and 
the apex of the lung contralateral to the pathological parathyroid gland close to unity would 
suggest the complete excision of the hyperactive parathyroidal tissue. These authors 
(Rubello et al., 2003a) describe an ex vivo index (parathyroid gland/background) higher than 
40% in all cases of adenoma and in at least one of the pathological parathyroid gland of a 
multiglandular disease.  
Friedman et al. (2007) consider a background measurement made at the skin of the neck, in 
the lateral zone of the incision. According to their findings, the ex vivo counting of the 
normal parathyroid glands is significantly lower than that of the pathological glands, for 
which the percentage over background exceeds 40%. 
We use the in vivo counting to guide surgeon excision. To do so, we obtain a background 
measurement after incision by placing the probe over the thyroidal isthmus. Once the 
incision is made, an operative mapping is taken in the four quadrants for bilateral surgeries 
or in the region of the suspected adenoma for MIP. The in vivo index is defined as the ratio 
of in vivo counting to background (García-Talavera et al., 2010, 2011).  
The ex vivo counting is also used for differentiating between pathological parathyroid tissue 
and fat, lymphatic nodes, or thymus (Friedman et al., 2007; Norman & Chheda, 1997). We 
performed this measuring the parathyroid gland outside the operative field (ex vivo 
counting), and comparing it with the empty bed (ex vivo index). As stated below, we use the 
ioPTHi to confirm the complete exeresis of the pathological parathyroid tissue. 
2.2.1 Adenoma vs hyperplasia 
The traditional procedure to differentiate between adenomas and hyperplasic glands is the 
histological evaluation by frozen section. However, surgeons do not always provide enough 
tissue to the pathologist or the tissue sections are not cut appropriately, which results in a 
substantial false positive and false negative rate (Murphy & Norman, 1999). Furthermore, 
frozen section analysis is often unreliable in distinguishing hyperfunctioning and normally 
active parathyroid tissue, as this method only provides a view of a single portion of the 
gland (Irvin & Bagwell, 1979; Murphy & Norman, 1999), with specimens often interpreted 
as “non diagnostic parathyroid tissue” (Irvin & Bagwell, 1979). Dewan et al. (2005) report 
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that errors in gross tissue evaluation, by both the surgeon and pathologist, give rise to a 6% 
operative failure rate. 
Because of these drawbacks, the ex vivo and the in vivo counting have been used by  
some authors to differentiate between adenomas and hyperplasic glands. According to 
Murphy & Norman (1999), the ex vivo counting in adenomas differs from that  
in hyperplastic glands: <16% radioactivity over background for non-parathyroidal tissues 
and normal and hyperplastic parathyroid glands vs 599% (variation range: 18%-136%) 
for adenomas. Mc Greal et al. (2001) also found statistically significant differences in  
the ex vivo index between single adenomas and other types of tissues; they concluded  
that, in patients with a MIBI positive scintigraphy, a 20% counting over background for 
the excised tissue gives a strong evidence of a single adenoma while the counting for 
lymph nodes, thyroid tissue and normal or hyperplastic glands would not exceed the  
said value.  
On the contrary, Friedman et al. (2007) argue that the ex vivo counting can differentiate 
between pathological parathyroid glands and other tissues, but it is unable to differentiate 
between adenomas and hyperplasias, given that, although the counting was statistically 
higher for adenomas than for hyperplasias, the results overlapped in some cases. This view 
is supported by Chen et al. (2003), who did not find statistically differences between the in 
vivo counting of adenomas and hyperplasias. On the contrary, Ugur et al. (2006), propose an 
in vivo index cut-off value of 103% to differentiate between adenoma and hyperplasic 
glands, achieving 82.5% sensitivity and 65% specificity. 
In our study (García-Talavera et al., 2011), significant differences were found, on one hand, 
between the in vivo index for adenomas and double adenomas (p=0.009) and, on the other, 
between adenomas and hyperplasias (p=0.002). However for adenomas and multiglandular 
disease, there is a region of overlapping values. Using a cut-off value of 1.51, we obtained a 
67% sensitivity and 87% specificity. With this cut-off value, we reached a PPV of 95% that 
would allow, in positive cases, to exclude the existence of a second pathological gland with 
a high confidence. Rubello et al. (2006b) and EANM parathyroid guidelines (Hindié et al., 
2009) reported as well that an in vivo index greater than 1.5 strongly suggests the presence of 
a solitary adenoma.  
2.2.2 Glandular size 
The glandular size and weight have been described to influence the counting of the 
abnormal glands. Ugur et al. (2004) described a correlation between the ex vivo counting and 
the size of the gland. Thus, he warns that large hyperplasic glands may behave like a 
parathyroid adenoma as with regard to their total count.  
Friedman et al. (2007) concluded, as well, that the percentage of radioactivity above 
background is proportional to the mass of the specimen, which has significant implications 
when decision are being made based on radioactive counts obtained from whole excised 
parathyroid adenomas vs biopsy specimens of hyperplastic or normal glands. 
On the contrary, in the experience of Chen et al. (2003), gland weight does not directly 
correlate with ex vivo radionuclide counts. They explained that although very large glands 
tended indeed to have high ex vivo counts, the variation range of ex vivo counts for smaller 
glands was very large. 
www.intechopen.com
 
Hyperparathyroidism 
 
40
In our experience, a significant non-linear correlation (Spearman, p=0.005) is found between 
in vivo counting and gland volume (García-Talavera et al., 2011). 
2.3 Benefits and failures of the probe 
The reported benefits of the probe are manifold. As mentioned above, the probe may be 
used to differentiate between parathyroid adenoma and hyperplasia as well as between 
pathological parathyroid glands and other macroscopically similar tissues, as for instance, 
adipose and lymphoid tissues [Murphy & Norman, 1999].   
Besides, as often reported (Berland et al., 2005; Chen et al., 2003; Rubello et al., 2003a; Weigel 
et al., 2005; García-Talavera et al., 2010), an important contribution of the probe is its 
usefulness in locating ectopic glands: at deep cervical locations, in the mediastinum or in an 
intrathyroid location. 
In particular the gamma probe is very helpful in patients with persistent or recurrent PHPT 
(Bonjer et al., 1997), and in patients with previous cervical surgery due to thyroid or 
parathyroid disease (Dackiw et al., 2000). For these patients, the technique allows the extent 
of reoperation to be minimized reducing complications (Casara et al., 2002). At this point, it 
must be stated that in cases of persistent disease the failure of the surgery is usually caused 
by an ectopic adenoma and the detection of this latter improves with the use of the probe. 
Compared to the scintigraphy (Chen et al., 2005; García-Talavera et al., 2010, 2011), the 
probe eliminates FP scintigraphical results, contributing to minimize the extent of surgical 
intervention. It also avoids the persistence of the disease detecting FN scintigraphic results, 
because of small adenomas, but especially due to multiglandular disease. This supports the 
theory that a radioguided surgery can be performed despite a negative scintigraphy (Mc 
Greal et al., 2001; Rubello et al. 2006b). Dackiw et al. (2000) described possible causes of 
these negative results: for instance, a relatively weak labeling of the parathyroid tissue with 
MIBI, relatively small parathyroid adenomas, or background interferences (mediastinal 
structures, multinodular thyroid gland). In patients with negative scintigraphic results, the 
advantages of the intraoperative gamma probe over the preoperative scintigraphy include 
the ability to move interfering structures (thyroid) out of the way of the probe and the 
ability to perform ex vivo counting. Nevertheless, these authors only recommend using 
intraoperative probe in carefully selected patients with negative or unequivocally MIBI 
scintigraphies that are undergoing re-operative procedures. In such patients, Norman & 
Denham (1998) advocated to suppress thyroid function preoperatively with thyroxine.  
As previously mentioned, the probe allows verifying the efficacy and completeness of the 
parathyroidectomy. In this way, it can minimize the extent of dissection (Chen et al., 2003) 
and allows to perform a MIP, shortening surgery time and hospital stays (Rubello et al., 
2003a) thus decreasing costs (Flynn et al., 2000; Goldstein et al., 2000) and improving the 
esthetic results without major surgical complications. 
There are, however, certain shortcomings to radioguided surgery. The most important is its 
poor use when there is concomitant thyroid pathology (Bonjer et al., 1997). Some authors 
discourage its use for such patients, since the existence of thyroid nodules with MIBI uptake 
largely worsens its performance except in those with ectopic or deep cervical adenomas. To 
detect nodules with a high uptake (which may lead to false positive scintigraphy and errors 
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in radioguided surgery), it has been proposed to acquire a preoperative double-tracer 
scintigraphy (Casara et al., 2002). Instead, we perform other imaging techniques 
(ultrasonography, CT or MRI) in addition to the scintigraphy.  
The EANM (Hindié et al., 2009) has recently issued guidelines on the application to 
parathyroidectomy of the gamma detecting probe, as well as scintigraphy and other 
imagining localization techniques. They review the main indications for the use of the 
gamma probe, which, as stated above, do not include patients with concomitant thyroid 
nodules. However, in our experience (García-Talavera et al., 2010), patients with 
concomitant thyroid pathology should not be excluded a priori from MIP, provided that 
other adjuvant techniques are used along with the gamma probe. The ioPTHi determination 
can detect FP and indicates whether surgery can be ended or should be continued or 
converted into a unilateral or bilateral approach. 
Another shortcoming is that the sensitivity of the gamma probe decreases in cases of 
multiglandular desease (Bonjer et al., 1997; Dackiw et al., 2000). The ioPTHi determination 
has an important role to avoid the rate of FN, as well (García-Talavera et al., 2011).   
Despite the many reports supporting radioguided surgery in patients with PHPT, several 
authors are not so enthusiastic about this technology. Many of them pointed out the high 
success rate of parathyroidectomy when performed by experienced surgeons and 
emphasize that radioguided techniques do not routinely provide any additional 
information. In a series of 60 patients with PHPT, Inabnet et al. (2002) found that although 
radioguided surgery was helpful in 40% of cases, it provided confusing or inaccurate 
information in 48% of cases. Jaskowiak et al. (2002) found radoguided technique only 
helpful in 22% of patients (out of 57 patients with PHPT). However, these authors admit the 
benefits of this technique in cases of persistent or recurrent PHPT and in the re-operative 
neck. They added that the gammaprobe localization proved also useful in some cases of 
ectopic glands. 
In our opinion, although the results may vary depending, among other factors, on the 
skilfulness of surgeon and probe operator, the gamma probe is a useful tool, especially 
allowing a MIP or unilateral surgery and localizing adenomas in ectopic locations. This 
technique, in addition to preoperative localization imaging (double phase scintigraphy), 
increased the overall success rate from 79% to 94% (Table 1), even in a population with a 
high prevalence of thyroid pathology (García-Talavera et al., 2010). We use this technique as 
well in reoperations (previous thyroid or parathyroid surgery) with good results, and in 
bilateral neck exploration where it shortens surgery time and improves the location of 
ectopic adenomas. 
 
 
Without thyroid 
pathology 
With thyroid 
pathology 
Total 
Scintigraphy 85.2% 69.7% 79.3% 
Scintigraphy & probe 96.3% 90.9% 94.3% 
Scintigraphy & ioPTHi 94.4% 93.9% 94.3% 
All techniques 98.2% 97.0% 97.7% 
Table 1. Success of the combined use of the techniques regarding to the presence or not of 
concomitant thyroid pathology. 
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3. Intra-operative intact PTH (ioPTHi) 
In the last few years, ioPTHi determination has been incorporated into hyperparathyroidism 
surgery, as a means of detecting the decrease of this hormone in plasma following excision 
of all the diseased parathyroid tissue. Information obtained with pre-operative localization 
procedures, together with the biological confirmation by ioPTHi that the whole 
hyperfunctioning parathyroid tissue has dried up, makes a unilateral neck approach 
possible, in many cases, thereby avoiding extensive surgery and increasing the success rate. 
In 1988, Nussbaum et al. described a method for rapid ioPTHi detection, namely, by 
modifying the non-competitive radioimmunoassay technique (IRMA) employed for serum 
iPTH quantification. Since then, many authors have successfully used this procedure, which 
requires a radioactive isotope and takes about 30-35 min (from sample collection till the 
result is available).  
Some years later, we saw the commercialisation of a chemiluminescent immunometric assay 
(ICMA), which has several advantages over the IRMA. With a reduction in total assay time 
to 15 minutes and without the need for radioactive isotopes, it is even possible to conduct 
this test in the operating theatre. This technique, developed and documented by Irvin et al. 
(1993), is being employed, with good results, in surgical treatment of primary and secondary 
hyperparathyroidism. In a latter study, Irvin & Deriso (1994) assessed that a reduction of 
more than 50%, ten minutes after excision, is indicative of total extirpation of the diseased 
parathyroid tissue and highly suggestive of post-operative eucalcemia. With this procedure, 
they obtained sensitivity and specificity figures of 95% and 100%, respectively. 
3.1 Reference values 
Carneiro et al. (2003) compared the so-called Miami criterion (ioPTHi drop ≥ 50%, 10 
minutes after gland excision, with respect to the maximum of the pre-incision and the pre-
excision level,) to other five published criteria used to predict complete resection. In their 
study, the Miami criterion showed the highest accuracy. The use of any of the others would 
minimize the false positive results, but would cause unnecessary neck explorations in 
searching for multiglandular disease. 
Riss et al. (2007) compared the incidence of false positives, using three different criteria, 
specifically, the “Vienna” criterion (> 50% decline of the pre-incision baseline level, 10 
minutes after excision), the “Hale” criterion (decline of the ioPTHi level to ≤ 35 pg/ml, 
within 15 minutes after excision) and the “Miami” criterion. In 207 patients, the use of the 
Vienna criteria was shown to produce a lower incidence of false positives, thereby 
decreasing the risk of multiglandular disease when compared to the other criteria 
evaluated. 
Bergson et al. (2004) took samples before skin incision or induction of anesthesia (baseline 
1); pre-excision, after identification but before removal of an abnormal gland (baseline 2); at 
5 and 10 minutes after gland excision; and at variable intervals thereafter. In cases of 
multiglandular disease, samples were generally drawn at 10 minutes intervals after each 
gland was excised. A decresease in ioPTHi level by 50% from baseline 1 and into the normal 
range (< 65 pg/ml) was used to indicate successful removal of all abnormal parathyroid 
tissue. 
www.intechopen.com
Radio-Guided Surgery and Intraoperative iPTH  
Determination in the Treatment of Primary Hyperparathyroidism 
 
43 
Nevertheless, Thompson et al. (1999) suggested that a cut-off of 70% would result in the 
identification of a higher proportion of patients with multiglandular disease. On the other 
hand, Dackiw et al. (2000) proposed that, when using the ioPTHi determination in patients 
with MEN1, it is reasonable to apply the same target used by Clary et al. (1997) —an 
approximately 80% decrease in ioPTHi level— in patients with secondary 
hyperparathyroidism and parathyroid hyperplasia. Analogously, for Hughes et al. (2011), if 
a multiglandular disease is detected during the operation, a more stringent criterion for 
determining adequate resection can improve cure rates. They reported that a decrease of ≥ 
75% and into the normal range improves the PPV from 93.2 to 96.6, when compared to the 
standard criterion of a 50% decrease in the ioPTHi baseline level.  
We use the classic criteria of a > 50% decrease of ioPTHi, 10 minutes after gland extirpation, 
compared to the pre-incision level (baseline). As for persistent hyperfunctioning 
parathyroid tissue, we take samples 10 minutes after every gland excision. 
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Fig. 3. Distribution of the decresing of the ioPTHi level at 10 minutes in a population of 78 
patientes with surgery for PHPT (mean=66.8%; SD=18.8%)  
(García-Talavera. Unpublished data). 
3.2 Indications 
Dackiw et al. (2000) summarize the following main indications of the ioPTHi determination:  
1. Predicting clinical cure or indicating the need for bilateral neck exploration and the 
likehood of multiglandular disease in patients undergoing a unilateral or minimally 
invasive parathyroidectomy.  
2. Predicting the cure in patients undergoing an anatomically directed reoperative 
parathyroidectomy.  
3. Indicating the need for additional resection of hyperplasic parathyroid tissue in patients 
with secondary hyperparathyroidism and MEN1.  
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4. Suggesting the potential need for autografting and cryopreservation in patients with 
final ioPTHi values below the lower limit of detection, particularly in patients 
undergoing a reoperative parathyroidectomy and in patients undergoing a near-total 
parathyroid excisions. 
In addition, the final ioPTHi level has been described to predict those at risk for recurrence 
after parathyroidectomy. Heller & Blumberg (2009) reported that those patients with a final 
level of 40 pg/ml or higher are at risk of having persistent hyperparathyroidism and should 
be followed-up closely and indefinitely following parathyroidectomy. 
The ioPTHi determination has been described, as well, to be useful in detecting false 
negatives of imaging techniques. Sugino et al. (2010) divided patients who underwent 
minimally invasive parathyroidectomy into two groups, depending on the determination or 
not of the ioPTHi. The overall cure rate increased from 93.1%, in the group without ioPTHi 
determination, to 97.5%, in the group with ioPTHi. These authors concluded that although 
preoperative localization studies are accurate and essential, ioPTHi monitoring improves 
the cure rate. The ioPTHi monitoring is a valuable adjunct to achieve adequate 
intraoperative decision-making, recognizing and resecting additional image-negative 
hyperfunctioning lesions. 
Finally, as mention before, it is a useful tool to detect false positives of the gamma probe in 
patients with concomitant thyroid pathology (García-Talavera et al., 2010). 
3.3 Controversy on the ioPTHi usefulness 
At the beginning, the use of the ioPTHi was considered as a tool with a low rate of failures, 
but in the last few years several investigators have reported an important rate of inadequate 
drop of ioPTHi levels in the presence of persistent hyperfunctioning parathyroid tissue, 
especially in cases of double adenomas.  
Haciyanli et al. (2003) support that ioPTHi does not reliably predict double adenomas. The 
same conclusion was made by Gauger et al. (2010), who reviewed 20 cases of double 
adenomas identified at bilateral neck exploration, measuring ioPTHi although it was not 
used to guide surgical decision making. They found that in 55% of the cases, using ioPTHi 
to make a decision on the removal of all abnormal parathyroid tissue would have resulted in 
failure to detect the second adenoma. Siperstein et al. (2004) also studied ioPTHi in 350 
patients who had been underwent bilateral neck exploration after preoperative 99mTc-MIBI 
scintigraphy and ultrasonography. If a unilateral exploration based on the imaging test had 
been performed, ioPTHi level would have failed to predict the presence of multiglandular 
disease in 9% of patients. Multiglandular disease would have been missed in 15% of patients 
if a MIP had been performed. 
However, there are a lot of publications advocating for the use of this technique to improve 
the success of parathyroidectomy. Furtheremore, ioPTHi determination has been reported 
as the most accurate predictor of multiglandular disease (Sugg et al., 2004). In a smaller 
series, Stratmann et al. (2002) found that the ioPTHi measurement accurately predicted the 
presence of multiglandular disease in 8 out of 8 patients with PHPT suspected of having a 
solitary adenoma on preoperative MIBI scintigraphy. Kandil et al. (2009) studied 47 patients 
with double adenomas and concluded that ioPTHi monitoring accurately predicted the 
success of parathyroidectomy in 98% of patients with double adenomas.  
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In our experience, as we previously mentioned, the ioPTHi determination is a valuable 
method to detect FN of the gamma probe due to multiglandular disease. Furthermore, in 
association with the scintigraphy, it improved the success rate in our study from 79% to 94% 
(Table 1). Despite this fact, we agree with other authors that the ioPTHi technique is not 
without errors.  
3.4 Causes of failures in the ioPTHi technique 
Several factors have been associated to the inadequate drop in ioPTHi levels. Some authors 
have reported false positive decrease in ioPTHi levels, as Zettinig et al. (2002), who 
described the case of a recurrence hyperparathyroidism due to the existence of a suppressed 
double adenoma. The theoretical explanation is that in rare occasions smaller abnormal 
parathyroid glands can be suppressed and may become hypersecretory if they are left in situ 
after surgical removal of the larger gland. Regarding this matter, Sitges-Serra et al. (2010) 
reported that two-thirds of the patients with double adenomas showed a false-positive 
decline of ioPTHi after resection of the first adenoma. This appears to be due to the initial 
removal of the larger lesion when there are marked differences between the two enlarged 
glands. They think that extending ioPTHi sampling for 15-20 minutes after excision of the 
first adenoma (in search of a normalization of PTH levels) would be a good choice. 
Nevertheless, due to the low prevalence of double adenomas, adopting other criteria to define 
a biochemical intraoperative cure would lead to make surgery more tedious for more than 95% 
of patients with single gland disease submitted to limited surgery (it prolongs the operating 
room waiting time too much and may lead to spurious reconversions into bilateral neck 
exploration). Gordon et al. (1999) support these results; their group, on the validation of the 
quick ioPTHi assay, included 14 patients with double adenoma. These authors described that 4 
of 14 patients with double adenoma cases showed a greater than 50% decrease in ioPTHi after 
resection of the first lesion, which was always heavier than the second. 
Carneiro et al. (2003) specifically analyzed the false positive results in the decrease of ioPTHi 
in this series. One of them involved an undiagnosed parathyroid cancer, another was due to 
a verified technical assay error, and the third case had a very high pre-excision level from an 
intraoperative rupture of a parathyroid cyst. 
Another cause of failure in the ioPTHi determination is the existence of false negative 
decrease of the ioPTHi. Yang et al. (2001) described a possible cause; they reported a spike in 
parathyroid hormone level during exploration caused by the mobilization of the adenoma. 
This spike can be unrecognized if baseline values are measured during the early stages. Due 
to this fact, they changed their protocol by measuring ioPTHi at the time of neck incision, at 
the time of complete removal of the adenoma, and 10 minutes after excision. 
Some authors (Chen et al., 2005) related elder patients and high levels of creatinine to the 
lack of decrease of ioPTHi after a successful excision. In these cases, the half-life of iPTH 
may be greater than the 3 to 4 minutes, valid for the majority of patients. 
4. Choice among techniques 
There are different views regarding the association of intraoperative tools (frozen section, 
the gamma probe and the ioPTHi determination) during limited parathyroidectomy.  
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Some (as Jacobson et al., 2004) believe that selected patients with PHPT due to single-gland 
disease and unequivocally positive preoperative MIBI scintigraphy can safely and 
successfully be managed with a focused unilateral cervical exploration without either 
ioPTHi determination or use of the gamma probe. Smith et al. (2009) think, as well, that 
ioPTHi determination may be eliminated in MIP surgery in a carefully selected group of 
patients who have preoperative localizing MIBI scintigraphy with concordant US. In their 
experience, 2 concordant preoperative localization studies result in a 97% rate of 
successfully performed MIP vs an 80% success rate with one positive study alone. In the 
other hand, adding an ioPTHi measurement in patients with concordant preoperative 
studies provided only a minor benefit. If the ioPTHi were eliminated in these patients, it 
would be possible to reduce the cost associated with laboratory fees, operating room time, 
and anaesthesia time. 
Other authors use the ioPTHi determination with previous preoperative imaging 
techniques. For instance, Bergson et al. (2004) think that preoperative MIBI scintigraphy and 
ioPTHi measurement allow a successful MIP, with cure rates comparable to traditional 
results using bilateral neck exploration. In their experience, the ioPTHi allows an accurate 
identification of multiglandular disease in 88% of cases.  
Sidell et al. (2010) support the use of the ioPTHi and frozen section during 
parathyroidectomy because they help to maximize patient safety, improve confidence, and 
minimize operative failure. 
There are some investigators who support the use of the gamma probe alone, as Murphy & 
Norman (1999). They state that, if a tissue is removed from a patient with HPTP who has a 
positive MIBI scintigraphy and this tissue contains more than 20% of the radioactivity in the 
operative basin, frozen section analysis do not need to be performed and the intraoparative 
measurement of parathyroid hormone is unnecessary. According to these authors, the use of 
the ioPTHi is costly, time consuming, applicable primarily to patients with adenomas, and 
still with errors. In this group, we could include Goldstein et al. (2003) who reported an 
excellent cure rate for the radioguided MIP technique with a preoperative positive MIBI 
scintigraphy without ioPTHi determination. But these authors, consider the association of 
ioPTHi useful in some occasions, such as complicated reoperative settings or suspicion of 
multiglandular disease. 
There are several authors who trust in the association of techniques to achieve the highest 
success. Dackiw et al. (2000) would always combine preoperative MIBI imaging with the 
gamma probe and the ioPTHi determination when performing anatomically directed 
operations, including minimally invasive operations, to help ensure postoperative resolution 
of hypercalcemia. They claim that the intraoperative gamma probe localization is particularly 
useful in assisting in the identification of ectopic parathyroid adenomas, whereas the ioPTHi 
assists in the identification and management of patients with multiglandular deasease. Ugur et 
al. (2004) compared the ex vivo and in vivo counting to frozen section, and their conclusion is 
that the two former methods are more accurate than the latter. On the other hand, they 
consider the quick ioPTHi assay very helpful, especially in asymmetric hyperplasia cases, 
because large hyperplastic glands may produce radioactivity countings as high as adenomas 
do. Chen et al. (2003) found that radioguided surgery facilitated intraoperative localization 
(especially of ectopically located glands), allowed to give up intraoperative frozen section 
analysis, and was equally effective for adenomatous and hyperplastic parathyroid glands. 
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Nevertheless, they believe that the radioguided techniques complement the ioPTHi assay but 
cannot replace it. In a later publication, these authors (Chen et al., 2005) compared the use of 
MIBI scanning, radioguided surgery and ioPTHi determination. ioPTHi reached the highest 
sensitivity (99%), positive predictive value (99.6%) and accuracy (98%). The gamma probe 
obtained 93%, 88% and 83%, respectively, whereas the scintigraphy achieved 84%, 81%, and 
72%, respectively. In the EANM guidelines (Hindié et al., 2011), it is stated that, due to the 
good ability of the gamma probe to identify hyperactive parathyroid tissue, the probe can 
replace frozen section, but in order to confirm the complete parathyroid removal the gamma 
probe should be used in association with ioPTHi measurements. We support as well the 
combined use of techniques (scintigraphy, gamma probe and ioPTHi), reaching a success rate 
of 98% (see Table 1). 
5. Portable gamma camera 
Another useful tool in minimally invasive surgery which still requires more experience and 
validation is the portable gamma camera. The first portable gamma camera was patented by 
Soluri et al. (1997) and validated by Scopinaro et al. (1999) for sentinel lymph node biopsy in 
breast cancer patients. Nowadays these cameras have become smaller and lighter. They 
have a high degree of sensitivity and spatial resolution, with values approximated to those 
of the gamma probe. Moreover, dynamic real-time images can be taken, including lateral 
images of the neck and mediastinal space. 
Fuji et al. (2011) used a handheld semiconductor-based gamma camera. They included 
eleven patients with PHPT and positive scintigraphy, acquiring images before skin incision, 
after adenoma localization, after adenoma excision, and ex vivo imaging of the specimen. 
The gamma camera allowed them to intraoperatively identify and remove parathyroid 
adenomas in all cases. 
Ortega et al. (2007) made an intra-operative comparison of the utility of a conventional intra-
operative probe and a new-generation portable gamma camera. In addition, they 
determined ioPTHi so as to verify the total extirpation of parathyroid tissue. Consequently, 
the portable camera could be used together with the intra-operative probe or perhaps it 
could replace it, as has been suggested by these authors. In a later study, Cassinello et al. 
(2009) included 20 patients; in 15 cases, ioPTHi was not used for intraoperatively diagnosis 
and the miniature gamma camera was the only diagnostic tool employed to perform the 
operation. All cases were successfully operated by a MIP. They concluded that the portable 
gamma camera can be used as complementary to the standard tools or even to replace them, 
at least in selected cases of single adenomas.  
A possible benefit of this procedure is the application in patients with a thyroid disorder, as 
illustrated by Ferrer-Rebolleda et al. (2008). However, cost is its biggest disadvantage. As a 
result, its use would be only justified in centres with a wide range of applications (sentinel 
lymph node, ROLL, etc.). 
6. Conclusion 
Nowadays, thanks to the preoperative MIBI scintigraphy and the availability of 
intraoperative techniques, such as the gamma probe and the ioPTHi determination, MIP can 
be performed for the surgical treatment of PHPT. This surgical approach improves the 
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aesthetic results, decreases the morbidity and shortens the surgical time, hospital stay and 
consequently cost, achieving similar successful rates to the bilateral approach.  
The benefits of these two techniques (gamma probe and ioPTHi) in bilateral neck 
exploration have been documented as well. They shorten surgical time and guarantee the 
completeness of the exeresis of the pathological glands. The general applications of these 
techniques are the localization of ectopic adenomas (for the gamma probe) and the detection 
of multiglandular disease (for the ioPTHi test) which have been reported as the main causes 
of persistent and recurrent PHPT in the traditional surgery. There is a certain controversy 
over the protocols used (doses, time from injection to surgery, percentage of decrease in 
ioPTHi…) and accuracy of these tools depending on the authors. Consequently, PHPT 
surgical treatment differs in accordance with the surgeon’s preference and the availability of 
preoperative techniques.  
A new aiding tool in radioguided surgery is the use of the portable gamma camera, 
combined or not, to other intraoperative techniques. This new device seems to offer good 
results but further investigation is needed.  
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